LitAlert ~~ GeneLit.com

    • Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort.
    • MacInnis RJ, Knight JA, Chung WK, Milne RL, Whittemore AS, Buchsbaum R, Liao Y, Zeinomar N, Dite GS, Southey MC, Goldgar D, Giles GG, Kurian AW, kConFab Investigators, Andrulis IL, John EM, Daly MB, Buys SS, Phillips KA, Hopper JL, Terry MB.
    • J Natl Cancer Inst. 2020 Dec 10. pii: djaa178. doi: 10.1093/jnci/djaa178. [Epub ahead of print]

    Editorial:

    Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort

    • Only One-in-Three Breast Cancer Patients Offered Potentially Life Saving Genomic Test.
    • [No author given]
    • Clinical OMICs. 2020 Dec 9.
    • Breast metastasis from pelvic high-grade serous adenocarcinoma: a report of two cases.
    • Harada Y, Kubo M, Kai M, Yamada M, Zaguirre K, Ohgami T, Yahata H, Ohishi Y, Yamamoto H, Oda Y, Nakamura M.
    • Surg Case Rep. 2020 Dec 9;6(1):317. doi: 10.1186/s40792-020-01090-7.
    • Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    • Grandal B, Evrevin C, Laas E, Jardin I, Rozette S, Laot L, Dumas E, Coussy F, Pierga JY, Brain E, Saule C, Stoppa-Lyonnet D, Frank S, Sénéchal C, Lae M, De Croze D, Bataillon G, Guerin J, Reyal F, Hamy AS.
    • Cancers (Basel). 2020 Dec 8;12(12):E3681. doi: 10.3390/cancers12123681.
    • My Previvor Journey: My Robotic Mastectomy.
    • Mallonee R.
    • FORCE. Blog. 2020 Dec 7.
    • Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment.
    • Kurnit KC, Fleming GF, Lengyel E.
    • Obstet Gynecol. 2020 Dec 3. doi: 10.1097/AOG.0000000000004173. Epub ahead of print.
    • Cost-effectiveness of Maintenance Therapy Based on Molecular Classification Following Treatment of Primary Epithelial Ovarian Cancer in the United States.
    • Penn CA, Wong MS, Walsh CS.
    • JAMA Netw Open. 2020 Dec 1;3(12):e2028620. doi: 10.1001/jamanetworkopen.2020.28620.
    • Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling.
    • Wei Y, Ou T, Lu Y, Wu G, Long Y, Pan X, Yao D.
    • PeerJ. 2020 Nov 24;8:e10414. doi: 10.7717/peerj.10414.